SCHEMBL6551214

SCHEMBL6551214

C=CCCCC(=O)N1CCOC1=O

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 14/20 0.60
FAAH O00519 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21364511 0.95 NAAA (0.63) NAAAFAAH
SCHEMBL14310616 0.94 NAAA (0.66) NAAAFAAH
SCHEMBL2997563 0.90 NAAA (0.55) NAAAFAAH
SCHEMBL19825342 0.84 NAAA (0.80) NAAAFAAH
SCHEMBL8194221 0.80 NAAA (0.50) NAAAFAAH
SCHEMBL3957941 0.78 NAAA (0.87) NAAAFAAH
SCHEMBL3000361 0.78 NAAA (0.57) NAAAFAAH
SCHEMBL19825341 0.78 NAAA (0.71) NAAAFAAH
SCHEMBL4816798 0.77 NAAA (0.69) NAAAFAAH
SCHEMBL22953486 0.77 NAAA (0.97) NAAAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480964-A1 INHIBITEURS DE L'ANGIOGENESE Galderma Research & Development, S.N.C. (FR) 2004-12-01 EP disclosed
WO-2003040119-A1 ANGIOGENESIS INHIBITORS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2003-05-15 WO disclosed